Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer
High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer
Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer
Longterm Followup Finds Taxotere Improves Survival
Drug Combination Tested For B.C. Brain Metastases
Sunitinib May Be Associated With Cardiac Toxicity
BRCA Carriers Live Longer Than Those With Normal Gene
Rev/Vel/Dex Response Rate High In Phase I/II Study
FDA Approves Genetic Test For Breast Cancer Patients
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - In The Headlines: Private funding can’t replace federal funding—but it can help
- Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed
